Lorlatinib AE Management: Weight Gain and GI Issues
An expert discussion surrounding experience with managing weight gain and gastrointestinal adverse events associated with lorlatinib, addressing quality of life, symptom mitigation strategies, and maintaining treatment efficacy.
Video content above is prompted by the following:
- What has been your experience with the incidence and management of weight gain that some patients experience when taking lorlatinib?
- How do you discuss the impact of this symptom on QOL vs the benefit of treatment?
- How do you balance symptom management with maintaining treatment efficacy?
- What has been your experience with the incidence and management of GI adverse events associated with lorlatinib?
- Do you have any prophylactic tips for patients to mitigate GI issues?
- How does this compare to other ALK inhibitors?
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
